跳至主要内容
临床试验/TCTR20201101001
TCTR20201101001尚未招募未知

The efficacy of a super-long pulse 1064 Nd:YAG for localized noninvasive subcutaneous fat reduction of flanks; a prospective clinical trial

/A0 个研究点目标入组 17 人开始时间: 2020年11月1日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
17

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25 Years 至 60 Years(—)
性别
All

入选标准

  • Healthy subject who has clinically evident of excess fat tissue on flanks (love handles) area, defined by easily seen the fatty bulges extend on the sides of subjects’ waistline or easily pinch the fatty bulges on flanks without an effort.

排除标准

  • 1.Patients with weight gain or weight loss > 10% from baseline within 3 months.
  • 2.Pregnancy or Lactation
  • 3.Currently on treatments of obesity neither medications for weight loss such as metformin, liraglutide, and orlistat, nor procedures such as injectable of deoxycholic acid and liposuction.
  • 4.History of abdominal cosmetic or surgical treatments
  • 5.History of heat sensitivity, collagen vascular disorders including morphea, scleroderma, heat contact urticarial
  • 6.History of medical illness that could interfere or influence the wound healing process
  • 7.History of abnormal scars (keloid and hypertrophic scars) or hernia
  • 8.History of skin cancer, radiation therapy, or metal implants on treatment areas
  • 9.Active local or systemic infections or inflammation on treatment areas
  • 10.History of body dysmorphic disorders or other psychological conditions
  • 11.Any other conditions that would, in the professional opinion of the investigators, potentially affect the subject’s response or the integrity of the data or would pose an unacceptable risk to the subject.
  • 12.Subject is unable or unwilling to comply with the study requirements.
  • 13.Subject is currently enrolled in a clinical study of any other unapproved investigational drugs or devices.

研究者

发起方
/A

相似试验